Literature DB >> 498494

IgE antibodies to bee venom, phospholipase A, melittin and wasp venom.

R Jarisch, L Yman, A Boltz, I Sandor, A Janitsch.   

Abstract

Specific IgE antibodies against bee venom, phospholipase A, melittin and wasp venom have been examined in fifty patients with an unusually severe reaction after bee or wasp sting. Two thirds of the bee venom-sensitive patients also have detectable IgE antibodies to wasp venom. More than 50% of the wasp venom-sensitive patients are also allergic to bee venom. Phospholipase A and melittin IgE antibodies were found, respectively, in two thirds and one third of the bee venom-sensitive cases. Specific IgE antibody determinations by the Radioallergosorbent test play an essential role in the diagnostic work. After a reaction to hymenoptera stings both bee and wasp venom tests are necessary due to the high incidence of a false or incomplete identification of the stinging insect. Melittin, known for its potent pharmacological activity and possibly responsible for most of the side effects in bee venom immunotherapy, can probably not be excluded from therapeutic venom preparations since IgE antibodies to the melittin preparation were detected in one third of the cases.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 498494     DOI: 10.1111/j.1365-2222.1979.tb02518.x

Source DB:  PubMed          Journal:  Clin Allergy        ISSN: 0009-9090


  8 in total

Review 1.  Mast Cells and IgE can Enhance Survival During Innate and Acquired Host Responses to Venoms.

Authors:  Stephen J Galli; Philipp Starkl; Thomas Marichal; Mindy Tsai
Journal:  Trans Am Clin Climatol Assoc       Date:  2017

2.  Mast cells and IgE in defense against lethality of venoms: Possible "benefit" of allergy[].

Authors:  Stephen J Galli; Martin Metz; Philipp Starkl; Thomas Marichal; Mindy Tsai
Journal:  Allergo J Int       Date:  2020-03-02

3.  Incidence Rate of Hypersensitivity Reactions to Bee-Venom Acupuncture.

Authors:  Eun-Jung Lee; Yo-Chan Ahn; Young-Il Kim; Min-Seok Oh; Yang-Chun Park; Chang-Gue Son
Journal:  Front Pharmacol       Date:  2020-10-07       Impact factor: 5.810

4.  Programmable nanoparticle functionalization for in vivo targeting.

Authors:  Hua Pan; Jacob W Myerson; Lingzhi Hu; Jon N Marsh; Kirk Hou; Michael J Scott; John S Allen; Grace Hu; Susana San Roman; Gregory M Lanza; Robert D Schreiber; Paul H Schlesinger; Samuel A Wickline
Journal:  FASEB J       Date:  2012-10-09       Impact factor: 5.191

Review 5.  The Mast Cell-IgE Paradox: From Homeostasis to Anaphylaxis.

Authors:  Stephen J Galli
Journal:  Am J Pathol       Date:  2016-02       Impact factor: 4.307

Review 6.  Testing the 'toxin hypothesis of allergy': mast cells, IgE, and innate and acquired immune responses to venoms.

Authors:  Mindy Tsai; Philipp Starkl; Thomas Marichal; Stephen J Galli
Journal:  Curr Opin Immunol       Date:  2015-07-23       Impact factor: 7.486

Review 7.  IgE and mast cells in host defense against parasites and venoms.

Authors:  Philipp Starkl; Thomas Marichal; Kaori Mukai; Mindy Tsai; Stephen J Galli
Journal:  Semin Immunopathol       Date:  2016-05-25       Impact factor: 9.623

8.  A beneficial role for immunoglobulin E in host defense against honeybee venom.

Authors:  Thomas Marichal; Philipp Starkl; Laurent L Reber; Janet Kalesnikoff; Hans C Oettgen; Mindy Tsai; Martin Metz; Stephen J Galli
Journal:  Immunity       Date:  2013-10-24       Impact factor: 31.745

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.